Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lyndra Therapeutics

Lyndra Therapeutics
2015 FOUNDED
PRIVATE STATUS
51-60 EMPLOYEES
Grant LATEST DEAL TYPE
$13M LATEST DEAL AMOUNT
16 INVESTORS
Description

Developer of a novel therapeutic platform designed to sustain extended drug release in oral dosage form. The company's platform helps in the linear drug release of small molecules and peptides for seven days or more from each orally administered capsule, enabling physicians to improve patient care by improving therapeutic efficacy, thereby reducing side effects and generating cost-savings.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • 65 Grove Street
  • Suite 301
  • Watertown, MA 02472
  • United States

+1 (857) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lyndra Therapeutics’s full profile, request a free trial.

Lyndra Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 08-Nov-2018 $13M 000.00 Completed Startup
4. Early Stage VC (Series B) 11-Feb-2019 000.00 000.00 Completed Startup
3. Early Stage VC (Series A) 19-Apr-2017 000.00 000.00 000.00 Completed Startup
2. Grant 01-Jan-2017 $1.27M Completed Startup
1. Grant 01-Jan-2016 $300K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Lyndra Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Lyndra Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 (00000) 000 01-May-2018 00000 0000000 Pharmaceuticals 000 00000000 00
To view this company’s complete investment and acquisition history, request access »

Lyndra Therapeutics Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
FujiFilm Corporation Minority 000 0000 000000 0
Gates Family Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Gilead Sciences Corporation Minority 000 0000 000000 0
Hopu Investment Management PE/Buyout Minority 000 0000 000000 0
Orient Life Corporation Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Lyndra Therapeutics Executive Team (12)

Name Title Board
Seat
Contact
Info
Patricia Hurter President, Chief Executive Officer & Board Member
Jessica Ballinger Chief Operating Officer
Raymond Knox Chief Manufacturing Officer
Joel Dube Vice President of Finance and Business Planning, Treasurer

8 Former Executives

You’re viewing 4 of 12 executives. Get the full list »

Lyndra Therapeutics Board Members (7)

Name Representing Role Since Contact
Info
Catherine Reynolds Lyndra Therapeutics Chairman of the Board 000 0000
Edmund Harrigan MD Self Board Member 000 0000
Giovanni Traverso Ph.D Lyndra Therapeutics Co-Founder & Board Member 000 0000
Patricia Hurter Lyndra Therapeutics President, Chief Executive Officer & Board Member 000 0000
Robert Langer Ph.D Lyndra Therapeutics Co-Founder & Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 7 board members. Get the full list »